Back
DiaMedica Therapeutics, Inc. Stock Price Chart
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
55
DMAC
DiaMedica Therapeutics, Inc.
Last Price:
$8.49
Seasonality Move:
20.13%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is moderately bullish and DMAC is experiencing slight selling pressure.
DiaMedica Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.81 | Sell |
| 20-day SMA: | 8.64 | Sell |
| 50-day SMA: | 7.44 | Buy |
| 200-day SMA: | 5.48 | Buy |
| 8-day EMA: | 8.61 | Sell |
| 20-day EMA: | 8.4 | Buy |
| 50-day EMA: | 7.69 | Buy |
| 200-day EMA: | 6.06 | Buy |
DiaMedica Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 53.84 | Buy |
| Chaikin Money Flow: | -70020 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.36 - 9.16) | Buy |
| Bollinger Bands (100): | (5.61 - 7.99) | Buy |
DiaMedica Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for DiaMedica Therapeutics, Inc. Stock
Is DiaMedica Therapeutics, Inc. Stock a Buy?
-
DiaMedica Therapeutics, Inc. share price is 8.48 while DMAC 8-day simple moving average is 8.81, which is a Sell signal.
-
The stock price of DMAC is 8.48 while DiaMedica Therapeutics, Inc. 20-day SMA is 8.64, which makes it a Sell.
-
DiaMedica Therapeutics, Inc. 50-day simple moving average is 7.44 while DMAC share price is 8.48, making it a Buy technically.
-
DMAC stock price is 8.48 and DiaMedica Therapeutics, Inc. 200-day simple moving average is 5.48, creating a Buy signal.
DMAC Technical Analysis vs Fundamental Analysis
Buy
55
DiaMedica Therapeutics, Inc. (DMAC)
is a Buy
Is DiaMedica Therapeutics, Inc. a Buy or a Sell?
-
DiaMedica Therapeutics, Inc. stock is rated a BuyThe current DiaMedica Therapeutics, Inc. [DMAC] share price is $8.48. The Score for DMAC is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
DiaMedica Therapeutics, Inc. Stock Info
Market Cap:
441.6M
Price in USD:
8.48
Share Volume:
630.2K
DiaMedica Therapeutics, Inc. 52-Week Range
52-Week High:
10.42
52-Week Low:
3.19
Buy
55
DiaMedica Therapeutics, Inc. (DMAC)
is a Buy
DiaMedica Therapeutics, Inc. Share Price Forecast
-
What is the DiaMedica Therapeutics, Inc. stock price today?The DiaMedica Therapeutics, Inc. stock price is 8.48 USD today.
-
Will DMAC stock go up or go down?DiaMedica Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is DiaMedica Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, DiaMedica Therapeutics, Inc. is not overvalued.
Is DiaMedica Therapeutics, Inc. Stock a Buy?
-
DiaMedica Therapeutics, Inc. share price is 8.48 while DMAC 8-day exponential moving average is 8.61, which is a Sell signal.
-
The stock price of DMAC is 8.48 while DiaMedica Therapeutics, Inc. 20-day EMA is 8.40, which makes it a Buy.
-
DiaMedica Therapeutics, Inc. 50-day exponential moving average is 7.69 while DMAC share price is 8.48, making it a Buy technically.
-
DMAC stock price is 8.48 and DiaMedica Therapeutics, Inc. 200-day simple moving average is 6.06, creating a Buy signal.
Fundamental Analysis of DiaMedica Therapeutics, Inc.
Is DiaMedica Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.13 per share, and a decrease next year of $0.04 per share.
Technical Analysis of DiaMedica Therapeutics, Inc.
Should I short DiaMedica Therapeutics, Inc. stock?
-
DMAC Moving Average Covergence Divergence (MACD) indicator is 0.36, suggesting DiaMedica Therapeutics, Inc. is a Buy
-
DiaMedica Therapeutics, Inc. Relative Strength Index (RSI) is 53.84, which suggest DiaMedica Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for DiaMedica Therapeutics, Inc. is (7.36 - 9.16), which suggest DiaMedica Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for DiaMedica Therapeutics, Inc. is (5.61 - 7.99), which suggest DiaMedica Therapeutics, Inc. is a Buy
* DiaMedica Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.